Researchers at the University of Barcelona (UB) are taking part in a consortium working on the research and development of a new drug to treat the cognitive and motor decline associated with the disea...
Read moreThe idea of the project is to obtain cells with the patient mutations, develop organoids, explore the possibility of gene editing processes for different mutations and create a platform for drug testi...
Read moreIt has been published a study in the journal Brain that reveals connections between two devastating brain diseases: Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia.
Read moreUn nuevo estudio muestra indicios de que, en circunstancias extraordinarias, el alzhéimer puede transmitirse por un mecanismo similar al de los priones. Para los expertos, el hallazgo mejorará tanto...
Read moreThe work is based on data from the UK Biobank database and has made it possible to analyze information from more than 260,000 people. Its conclusions may allow a more detailed definition of future stu...
Read moreVivet Therapeutics announces the financing of EUR 4.9 million received from the French government to advance the development of a gene therapy for the treatment of cerebrotendinous xanthomatosis (CTX)...
Read moreResearchers at the Centre for Genomic Regulation (CRG) in Barcelona and the Spanish National Cancer Research Centre (CNIO) in Madrid have captured the world’s first high-resolution images of the ear...
Read moreLas moléculas de RNA pequeño no codificante, junto con los métodos tradicionales, tienen potencial para mejorar la predicción del Alzheimer y su diagnóstico precoz
Read moreA research team from the University of Barcelona (UB) is taking part in a consortium to develop new therapeutic targets for diseases of the central nervous system, such as neurodegenerative pathologie...
Read moreLas proteínas en cuestión se construyen a partir de exones “crípticos”, es decir, partes anormales del ARN, las instrucciones de la célula para construir proteínas. Los exones crípticos apar...
Read moreThe fact that M324 is capable of reducing the abnormal accumulation of α-synuclein in neurons derived from stem cells of a Parkinson’s patient, highlights the therapeutic potential of this metaboli...
Read moreIt has been developed a bioinformatics tool for estimating the genetic risk of suffering common diseases such as diabetes, heart attacks or cancer in a certain population.
Read more